Search

Your search keyword '"Besselink, Marc G H"' showing total 324 results
Start Over Author "Besselink, Marc G H"
324 results on '"Besselink, Marc G H"'

1. Laparoscopic versus open resections in the posterosuperior liver segments within an enhanced recovery programme (ORANGE Segments): study protocol for a multicentre randomised controlled trial

Author

Kuemmerli, Christoph, Fichtinger, Robert S., Moekotte, Alma, Aldrighetti, Luca A., Aroori, Somaiah, Besselink, Marc G. H., D’Hondt, Mathieu, Díaz-Nieto, Rafael, Edwin, Bjørn, Efanov, Mikhail, Ettorre, Giuseppe M., Menon, Krishna V., Sheen, Aali J., Soonawalla, Zahir, Sutcliffe, Robert, Troisi, Roberto I., White, Steven A., Brandts, Lloyd, van Breukelen, Gerard J. P., Sijberden, Jasper, Pugh, Siân A., Eminton, Zina, Primrose, John N., van Dam, Ronald, and Hilal, Mohammed Abu

Published
2022
Full Text
View/download PDF

2. Eligibility for Liver Transplantation in Patients with Perihilar Cholangiocarcinoma

Author

Vugts, Jaynee J. A., Gaspersz, Marcia P., Roos, Eva, Franken, Lotte C., Olthof, Pim B., Coelen, Robert J. S., van Vugt, Jeroen L. A., Labeur, Tim A., Brouwer, Lieke, Besselink, Marc G. H., IJzermans, Jan N. M., Darwish Murad, Sarwa, van Gulik, Thomas M., de Jonge, Jeroen, Polak, Wojciech G., Busch, Olivier R. C., Erdmann, Joris L., Groot Koerkamp, Bas, and Buettner, Stefan

Published
2021
Full Text
View/download PDF

5. Impact of the COVID-19 pandemic on surgical care in the Netherlands

Author

De Graaff, Michelle R, Hogenbirk, Rianne N M, Janssen, Yester F, Elfrink, Arthur K E, Liem, Ronald S L, Nienhuijs, Simon W, De Vries, Jean Paul P M, Elshof, Jan Willem, Verdaasdonk, Emiel, Melenhorst, Jarno, Van Westreenen, H L, Besselink, Marc G H, Ruurda, Jelle P, Van Berge Henegouwen, Mark I, Klaase, Joost M, Den Dulk, Marcel, Van Heijl, Mark, Hegeman, Johannes H, Braun, Jerry, Voeten, Daan M, Würdemann, Franka S, Warps, Anne Loes K, Alberga, Anna J, Suurmeijer, J Annelie, Akpinar, Erman O, Wolfhagen, Nienke, Van Den Boom, Anne Loes, Bolster-van Eenennaam, Marieke J, Van Duijvendijk, Peter, Heineman, David J, Wouters, Michel W J M, Kruijff, Schelto, Helleman, J N, Koningswoud-terhoeve, C L, Belt, E, Van Der Hoeven, J A B, Marres, G M H, Tozzi, F, Von Meyenfeldt, E M, Coebergh, R R J, Van Den Braak, H.P., Rijken, A M, Balm, R, Daams, F, Dickhoff, C, Eshuis, W J, Gisbertz, S S, Zandbergen, H R, Geelkerken, R H, Halfwerk, F R, Biomedical Signals and Systems, TechMed Centre, Multi-Modality Medical Imaging, Biomechanical Engineering, Engineering Organ Support Technologies, Digital Society Institute, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Surgery, MUMC+: MA Heelkunde (9), RS: NUTRIM - R2 - Liver and digestive health, Cardiothoracic Surgery, Dermatology, Cancer Center Amsterdam, Cardio-thoracic surgery, Obstetrics and gynaecology, Amsterdam Reproduction & Development (AR&D), CCA - Cancer Treatment and Quality of Life, CCA - Imaging and biomarkers, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Graduate School, ​Robotics and image-guided minimally-invasive surgery (ROBOTICS), Groningen Institute for Organ Transplantation (GIOT), Value, Affordability and Sustainability (VALUE), and Guided Treatment in Optimal Selected Cancer Patients (GUTS)

Subjects
COMPLICATIONS, HIP, SDG 3 - Good Health and Well-being, DUTCH INSTITUTE, MULTICENTER, Surgery, COHORT
Abstract

During the COVID-19 pandemic, a 13.6 per cent reduction in the number of surgical procedures performed was observed in 2020. Despite great pressure on healthcare, the COVID-19 pandemic did not cause an increase in adverse surgical outcomes, and oncological surgery-related duration of hospital and ICU stay were significantly shorter.Background The COVID-19 pandemic caused disruption of regular healthcare leading to reduced hospital attendances, repurposing of surgical facilities, and cancellation of cancer screening programmes. This study aimed to determine the impact of COVID-19 on surgical care in the Netherlands. Methods A nationwide study was conducted in collaboration with the Dutch Institute for Clinical Auditing. Eight surgical audits were expanded with items regarding alterations in scheduling and treatment plans. Data on procedures performed in 2020 were compared with those from a historical cohort (2018-2019). Endpoints included total numbers of procedures performed and altered treatment plans. Secondary endpoints included complication, readmission, and mortality rates. Results Some 12 154 procedures were performed in participating hospitals in 2020, representing a decrease of 13.6 per cent compared with 2018-2019. The largest reduction (29.2 per cent) was for non-cancer procedures during the first COVID-19 wave. Surgical treatment was postponed for 9.6 per cent of patients. Alterations in surgical treatment plans were observed in 1.7 per cent. Time from diagnosis to surgery decreased (to 28 days in 2020, from 34 days in 2019 and 36 days in 2018; P < 0.001). For cancer-related procedures, duration of hospital stay decreased (5 versus 6 days; P < 0.001). Audit-specific complications, readmission, and mortality rates were unchanged, but ICU admissions decreased (16.5 versus 16.8 per cent; P < 0.001). Conclusion The reduction in the number of surgical operations was greatest for those without cancer. Where surgery was undertaken, it appeared to be delivered safely, with similar complication and mortality rates, fewer admissions to ICU, and a shorter hospital stay.Lay Summary COVID-19 has had a significant impact on healthcare worldwide. Hospital visits were reduced, operating facilities were used for COVID-19 care, and cancer screening programmes were cancelled. This study describes the impact of the COVID-19 pandemic on Dutch surgical healthcare in 2020. Patterns of care in terms of changed or delayed treatment are described for patients who had surgery in 2020, compared with those who had surgery in 2018-2019. The study found that mainly non-cancer surgical treatments were cancelled during months with high COVID-19 rates. Outcomes for patients undergoing surgery were similar but with fewer ICU admissions and shorter hospital stay. These data provide no insight into the burden endured by patients who had postponed or cancelled operations.

Published
2022

6. Correction to: Eligibility for Liver Transplantation in Patients with Perihilar Cholangiocarcinoma

Author

Vugts, Jaynee J. A., Gaspersz, Marcia P., Roos, Eva, Franken, Lotte C., Olthof, Pim B., Coelen, Robert J. S., van Vugt, Jeroen L. A., Labeur, Tim A., Brouwer, Lieke, Besselink, Marc G. H., IJzermans, Jan N. M., Murad, Sarwa Darwish, van Gulik, Thomas M., de Jonge, Jeroen, Polak, Wojciech G., Busch, Olivier R. C., Erdmann, Joris L., Koerkamp, Bas Groot, and Buettner, Stefan

Published
2021
Full Text
View/download PDF

9. Fluid hydration to prevent post-ERCP pancreatitis in average- to high-risk patients receiving prophylactic rectal NSAIDs (FLUYT trial): study protocol for a randomized controlled trial

Author

Smeets, Xavier J. N. M., da Costa, David W., Fockens, Paul, Mulder, Chris J. J., Timmer, Robin, Kievit, Wietske, Zegers, Marieke, Bruno, Marco J., Besselink, Marc G. H., Vleggaar, Frank P., van der Hulst, Rene W. M., Poen, Alexander C., Heine, Gerbrand D. N., Venneman, Niels G., Kolkman, Jeroen J., Baak, Lubbertus C., Römkens, Tessa E. H., van Dijk, Sven M., Hallensleben, Nora D. L., van de Vrie, Wim, Seerden, Tom C. J., Tan, Adriaan C. I. T. L., Voorburg, Annet M. C. J., Poley, Jan-Werner, Witteman, Ben J., Bhalla, Abha, Hadithi, Muhammed, Thijs, Willem J., Schwartz, Matthijs P., Vrolijk, Jan Maarten, Verdonk, Robert C., van Delft, Foke, Keulemans, Yolande, van Goor, Harry, Drenth, Joost P. H., van Geenen, Erwin J. M., and for the Dutch Pancreatitis Study Group

Published
2018
Full Text
View/download PDF

12. Impact of the COVID-19 pandemic on surgical care in the Netherlands

Author

de Graaff, Michelle R., Hogenbirk, Rianne N. M., Janssen, Yester F., Elfrink, Arthur K. E., Liem, Ronald S. L., Nienhuijs, Simon W., de Vries, Jean-Paul P. M., Elshof, Jan-Willem, Verdaasdonk, Emiel, Melenhorst, Jarno, van Westreenen, H. L., Besselink, Marc G. H., Ruurda, Jelle P., Henegouwen, Mark I. van Berge, Klaase, Joost M., den Dulk, Marcel, van Heijl, Mark, Hegeman, Johannes H., Braun, Jerry, Voeten, Daan M., Wurdemann, Franka S., Warps, Anne-Loes K., Alberga, Anna J., Suurmeijer, J. Annelie, Akpinar, Erman O., Wolfhagen, Nienke, van den Boom, Anne Loes, Bolster-van Eenennaam, Marieke J., van Duijvendijk, Peter, Heineman, David J., Wouters, Michel W. J. M., Kruijff, Schelto, Waalboer, R.B., de Graaff, Michelle R., Hogenbirk, Rianne N. M., Janssen, Yester F., Elfrink, Arthur K. E., Liem, Ronald S. L., Nienhuijs, Simon W., de Vries, Jean-Paul P. M., Elshof, Jan-Willem, Verdaasdonk, Emiel, Melenhorst, Jarno, van Westreenen, H. L., Besselink, Marc G. H., Ruurda, Jelle P., Henegouwen, Mark I. van Berge, Klaase, Joost M., den Dulk, Marcel, van Heijl, Mark, Hegeman, Johannes H., Braun, Jerry, Voeten, Daan M., Wurdemann, Franka S., Warps, Anne-Loes K., Alberga, Anna J., Suurmeijer, J. Annelie, Akpinar, Erman O., Wolfhagen, Nienke, van den Boom, Anne Loes, Bolster-van Eenennaam, Marieke J., van Duijvendijk, Peter, Heineman, David J., Wouters, Michel W. J. M., Kruijff, Schelto, and Waalboer, R.B.

Abstract

BACKGROUND: The COVID-19 pandemic caused disruption of regular healthcare leading to reduced hospital attendances, repurposing of surgical facilities, and cancellation of cancer screening programmes. This study aimed to determine the impact of COVID-19 on surgical care in the Netherlands. METHODS: A nationwide study was conducted in collaboration with the Dutch Institute for Clinical Auditing. Eight surgical audits were expanded with items regarding alterations in scheduling and treatment plans. Data on procedures performed in 2020 were compared with those from a historical cohort (2018-2019). Endpoints included total numbers of procedures performed and altered treatment plans. Secondary endpoints included complication, readmission, and mortality rates. RESULTS: Some 12 154 procedures were performed in participating hospitals in 2020, representing a decrease of 13.6 per cent compared with 2018-2019. The largest reduction (29.2 per cent) was for non-cancer procedures during the first COVID-19 wave. Surgical treatment was postponed for 9.6 per cent of patients. Alterations in surgical treatment plans were observed in 1.7 per cent. Time from diagnosis to surgery decreased (to 28 days in 2020, from 34 days in 2019 and 36 days in 2018; P < 0.001). For cancer-related procedures, duration of hospital stay decreased (5 versus 6 days; P < 0.001). Audit-specific complications, readmission, and mortality rates were unchanged, but ICU admissions decreased (16.5 versus 16.8 per cent; P < 0.001). CONCLUSION: The reduction in the number of surgical operations was greatest for those without cancer. Where surgery was undertaken, it appeared to be delivered safely, with similar complication and mortality rates, fewer admissions to ICU, and a shorter hospital stay.

Published
2022

13. Impact of the COVID-19 pandemic on surgical care in the Netherlands

Author

MS CGO, Cancer, de Graaff, Michelle R., Hogenbirk, Rianne N. M., Janssen, Yester F., Elfrink, Arthur K. E., Liem, Ronald S. L., Nienhuijs, Simon W., de Vries, Jean-Paul P. M., Elshof, Jan-Willem, Verdaasdonk, Emiel, Melenhorst, Jarno, van Westreenen, H. L., Besselink, Marc G. H., Ruurda, Jelle P., Henegouwen, Mark I. van Berge, Klaase, Joost M., den Dulk, Marcel, van Heijl, Mark, Hegeman, Johannes H., Braun, Jerry, Voeten, Daan M., Wurdemann, Franka S., Warps, Anne-Loes K., Alberga, Anna J., Suurmeijer, J. Annelie, Akpinar, Erman O., Wolfhagen, Nienke, van den Boom, Anne Loes, Bolster-van Eenennaam, Marieke J., van Duijvendijk, Peter, Heineman, David J., Wouters, Michel W. J. M., Kruijff, Schelto, MS CGO, Cancer, de Graaff, Michelle R., Hogenbirk, Rianne N. M., Janssen, Yester F., Elfrink, Arthur K. E., Liem, Ronald S. L., Nienhuijs, Simon W., de Vries, Jean-Paul P. M., Elshof, Jan-Willem, Verdaasdonk, Emiel, Melenhorst, Jarno, van Westreenen, H. L., Besselink, Marc G. H., Ruurda, Jelle P., Henegouwen, Mark I. van Berge, Klaase, Joost M., den Dulk, Marcel, van Heijl, Mark, Hegeman, Johannes H., Braun, Jerry, Voeten, Daan M., Wurdemann, Franka S., Warps, Anne-Loes K., Alberga, Anna J., Suurmeijer, J. Annelie, Akpinar, Erman O., Wolfhagen, Nienke, van den Boom, Anne Loes, Bolster-van Eenennaam, Marieke J., van Duijvendijk, Peter, Heineman, David J., Wouters, Michel W. J. M., and Kruijff, Schelto

Published
2022

16. Additional file 3 of Laparoscopic versus open resections in the posterosuperior liver segments within an enhanced recovery programme (ORANGE Segments): study protocol for a multicentre randomised controlled trial

Author

Kuemmerli, Christoph, Fichtinger, Robert S., Moekotte, Alma, Aldrighetti, Luca A., Aroori, Somaiah, Besselink, Marc G. H., D���Hondt, Mathieu, D��az-Nieto, Rafael, Edwin, Bj��rn, Efanov, Mikhail, Ettorre, Giuseppe M., Menon, Krishna V., Sheen, Aali J., Soonawalla, Zahir, Sutcliffe, Robert, Troisi, Roberto I., White, Steven A., Brandts, Lloyd, van Breukelen, Gerard J. P., Sijberden, Jasper, Pugh, Si��n A., Eminton, Zina, Primrose, John N., van Dam, Ronald, and Hilal, Mohammed Abu

Abstract

Additional file 3: Supplementary document 1. SPIRIT checklist.

Published
2022
Full Text
View/download PDF

18. Implementation and first results of a mandatory, nationwide audit on liver surgery

Author

van der Werf, Leonie R., Kok, Niels F. M., Buis, Carlijn I., Grünhagen, Dirk J., Hoogwater, Frederik J. H., Swijnenburg, Rutger Jan, Dulk, Marcel den, Dejong, Kees C. H. C., Klaase, Joost M., de Boer, Marieke T., Besselink, Marc G. H., van Gullik, Thomas M., Hagendoorn, Jeroen, van Hillegersberg, Richard, Liem, Mike S. L., Molenaar, I. Quintus, Patijn, Gijs A., Porte, Robert J., te Riele, Wouter W., van Santvoort, Hjalmar C., Verhoef, Kees, Burgmans, Marc C., van Delden, Otto M., van der Leij, Christiaan, Meijerink, Martijn R., Moelker, Adriaan, Prevoo, Warner, Surgery, AGEM - Digestive immunity, AGEM - Re-generation and cancer of the digestive system, CCA - Cancer Treatment and Quality of Life, Radiology and Nuclear Medicine, ACS - Amsterdam Cardiovascular Sciences, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Other Research, MUMC+: MA Heelkunde (9), RS: NUTRIM - R2 - Liver and digestive health, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, CCA - Cancer Treatment and quality of life, Radiology and nuclear medicine, Groningen Institute for Organ Transplantation (GIOT), and Value, Affordability and Sustainability (VALUE)

Subjects
Male, Liver surgery, medicine.medical_specialty, RESECTION, ENHANCED RECOVERY, MEDLINE, Audit, 030230 surgery, Liver resections, MORBIDITY, 03 medical and health sciences, 0302 clinical medicine, Interquartile range, Hepatectomy, Humans, Medicine, Registries, Neoplasm Metastasis, Aged, Netherlands, Quality Indicators, Health Care, Retrospective Studies, Clinical Audit, Hepatology, business.industry, General surgery, Liver Neoplasms, Gastroenterology, Outcome measures, Retrospective cohort study, CHEMOTHERAPY, Middle Aged, CANCER, METASTASES, Population Surveillance, 030220 oncology & carcinogenesis, Female, Colorectal Neoplasms, business, Complication, Follow-Up Studies
Abstract

Background: The Dutch Hepato Biliary Audit (DHBA) was initiated in 2013 to assess the national quality of liver surgery. This study aimed to describe the initiation and implementation of this audit along with an overview of the results and future perspectives.Methods: Registry of patients undergoing liver surgery for all primary and secondary liver tumors in the DHBA is mandatory. Weekly, benchmarked information on process and outcome measures is reported to surgical teams. In this study, the first results of patients with colorectal liver metastases were presented, including results of data verification.Results: Between 2014 and 2017, 6241 procedures were registered, including 4261 (68%) resections for colorectal liver metastases. For minor- and major liver resections for colorectal liver metastases, the median [interquartile range] hospital stay was 6 [4-8] and 8 [6-12] days, respectively. A postoperative complicated course (complication leading to >14 days of hospital stay, reintervention or death) occurred in 26% and 43% and the 30-day/in-hospital mortality was 1% and 4%, respectively. The completeness of data was 97%. In 3.6% of patients, a complicated postoperative course was erroneously omitted.Conclusion: Nationwide implementation of the DHBA has been successful. This was the first step in creating a complete evaluation of the quality of liver surgery.

Published
2019

21. Additional file 1 of Impact of the COVID-19 pandemic on incidence and severity of acute appendicitis: a comparison between 2019 and 2020

Author

Scheijmans, Jochem C. G., Borgstein, Alexander B. J., Puylaert, Carl A. J., Bom, Wouter J., Bachiri, Said, Van Bodegraven, Eduard A., Amarins T. A. Brandsma, Brugge, Floor M. Ter, De Castro, Steve M. M., Couvreur, Roy, Franken, Lotte C., Gaspersz, Marcia P., De Graaff, Michelle R., Groenen, Hannah, Kleipool, Suzanne C., Kuypers, Toon J. L., Martens, Milou H., Mens, David M., Orsini, Ricardo G., Reneerkens, Nando J. M. M., Schok, Thomas, Sedee, Wouter J. A., Rad, Shahzad Tavakoli, Volders, José H., Weeder, Pepijn D., Prins, Jan M., Gietema, Hester A., Stoker, Jaap, Gisbertz, Suzanne S., Besselink, Marc G. H., and Boermeester, Marja A.

Abstract

Additional file 1: Figure S1. Duration of symptoms at presentation, cohort 2019 versus 2020. Table S1. Comparison of patients with uncomplicated appendicitis for 2019 pre-COVID cohort vs. 2020 COVID cohort. Table S2. Comparison of patients with complicated appendicitis and with symptoms for more than 24 h, 2019 pre-COVID cohort versus 2020 COVID cohort. Table S3. Comparison of patients with an age of 60 years or higher of the 2019 pre-COVID cohort and 2020 COVID cohort. Table S4. Comparison of conservatively treated patients with appendicitis, 2019 pre-COVID cohort versus 2020 COVID cohort. Table S5. Comparison of conservatively treated patients by final (imaging) diagnosis and imaging modality, 2019 pre-COVID cohort versus 2020 COVID cohort. Table S6. COVID-19 positive appendicitis patients.

Published
2021
Full Text
View/download PDF

22. Eligibility for Liver Transplantation in Patients with Perihilar Cholangiocarcinoma (vol 28, pg 1483, 2021)

Author

Vugts, Jaynee J. A., Gaspersz, Marcia P., Roos, Eva, Franken, Lotte C., Olthof, Pim B., Coelen, Robert J. S., van Vugt, Jeroen L. A., Labeur, Tim A., Brouwer, Lieke, Besselink, Marc G. H., IJzermans, Jan N. M., Murad, Sarwa Darwish, van Gulik, Thomas M., de Jonge, Jeroen, Polak, Wojciech G., Busch, Olivier R. C., Erdmann, Joris L., Koerkamp, Bas Groot, Buettner, Stefan, Vugts, Jaynee J. A., Gaspersz, Marcia P., Roos, Eva, Franken, Lotte C., Olthof, Pim B., Coelen, Robert J. S., van Vugt, Jeroen L. A., Labeur, Tim A., Brouwer, Lieke, Besselink, Marc G. H., IJzermans, Jan N. M., Murad, Sarwa Darwish, van Gulik, Thomas M., de Jonge, Jeroen, Polak, Wojciech G., Busch, Olivier R. C., Erdmann, Joris L., Koerkamp, Bas Groot, and Buettner, Stefan

Published
2021

27. Surveillance and Intervention in IPMN

Author

Balduzzi, A, van Huijgevoort, Nadine C. M., Marchegiani, G, Engelbrecht, Marc, Stoker, Jaap, Verheij, Joanne, Fockens, Paul, van Hooft, Jeanin E., Besselink, Marc G. H., Michalski, Christoph, Rosendahl, Jonas, Michl, Patrick, Kleeff, Jörg, Amsterdam Gastroenterology Endocrinology Metabolism, CCA - Cancer Treatment and Quality of Life, Graduate School, Radiology and Nuclear Medicine, Pathology, Gastroenterology and Hepatology, and Surgery

Subjects
cancer, Pancreas/pathology
Published
2020

30. Eligibility for Liver Transplantation in Patients with Perihilar Cholangiocarcinoma

Author

Vugts, Jaynee J. A., primary, Gaspersz, Marcia P., additional, Roos, Eva, additional, Franken, Lotte C., additional, Olthof, Pim B., additional, Coelen, Robert J. S., additional, van Vugt, Jeroen L. A., additional, Labeur, Tim A., additional, Brouwer, Lieke, additional, Besselink, Marc G. H., additional, IJzermans, Jan N. M., additional, Darwish Murad, Sarwa, additional, van Gulik, Thomas M., additional, de Jonge, Jeroen, additional, Polak, Wojciech G., additional, Busch, Olivier R. C., additional, Erdmann, Joris L., additional, Groot Koerkamp, Bas, additional, and Buettner, Stefan, additional

Published
2020
Full Text
View/download PDF

35. Gallstone Ileus

Author

Besselink, Marc G. H. and Kroeze, Jan

Published
2005

37. The association between obesity and outcomes in acute pancreatitis: an individual patient data meta-analysis

Author

Cancer, MS CGO, Smeets, Xavier J. N. M., Knoester, Iris, Grooteman, Karina, V, Singh, Vikesh K., Banks, Peter A., Papachristou, Georgios, I, Duarte-Rojo, Andres, Robles-Diaz, Guillermo, Kievit, Wietske, Besselink, Marc G. H., Verdonk, Robert C., Van Santvoort, Hjalmar C., Drenth, Joost P. H., Belias, Michael, Van Geenen, Erwin J. M., Cancer, MS CGO, Smeets, Xavier J. N. M., Knoester, Iris, Grooteman, Karina, V, Singh, Vikesh K., Banks, Peter A., Papachristou, Georgios, I, Duarte-Rojo, Andres, Robles-Diaz, Guillermo, Kievit, Wietske, Besselink, Marc G. H., Verdonk, Robert C., Van Santvoort, Hjalmar C., Drenth, Joost P. H., Belias, Michael, and Van Geenen, Erwin J. M.

Published
2019

40. Fluid hydration to prevent post-ERCP pancreatitis in average- to high-risk patients receiving prophylactic rectal NSAIDs (FLUYT trial) : study protocol for a randomized controlled trial

Author

Smeets, Xavier J N M, da Costa, David W, Fockens, Paul, Mulder, Chris J J, Timmer, Robin, Kievit, Wietske, Zegers, Marieke, Bruno, Marco J, Besselink, Marc G H, Vleggaar, Frank P, van der Hulst, Rene W M, Poen, Alexander C, Heine, Gerbrand D N, Venneman, Niels G, Kolkman, Jeroen J, Baak, Lubbertus C, Römkens, Tessa E H, van Dijk, Sven M, Hallensleben, Nora D L, van de Vrie, Wim, Seerden, Tom C J, Tan, Adriaan C I T L, Voorburg, Annet M C J, Poley, Jan-Werner, Witteman, Ben J, Bhalla, Abha, Hadithi, Muhammed, Thijs, Willem J, Schwartz, Matthijs P, Vrolijk, Jan Maarten, Verdonk, Robert C, van Delft, Foke, Keulemans, Yolande, van Goor, Harry, Drenth, Joost P H, van Geenen, Erwin J M, Dutch Pancreatitis Study Group, Smeets, Xavier J N M, da Costa, David W, Fockens, Paul, Mulder, Chris J J, Timmer, Robin, Kievit, Wietske, Zegers, Marieke, Bruno, Marco J, Besselink, Marc G H, Vleggaar, Frank P, van der Hulst, Rene W M, Poen, Alexander C, Heine, Gerbrand D N, Venneman, Niels G, Kolkman, Jeroen J, Baak, Lubbertus C, Römkens, Tessa E H, van Dijk, Sven M, Hallensleben, Nora D L, van de Vrie, Wim, Seerden, Tom C J, Tan, Adriaan C I T L, Voorburg, Annet M C J, Poley, Jan-Werner, Witteman, Ben J, Bhalla, Abha, Hadithi, Muhammed, Thijs, Willem J, Schwartz, Matthijs P, Vrolijk, Jan Maarten, Verdonk, Robert C, van Delft, Foke, Keulemans, Yolande, van Goor, Harry, Drenth, Joost P H, van Geenen, Erwin J M, and Dutch Pancreatitis Study Group

Published
2018

41. Fluid hydration to prevent post-ERCP pancreatitis in average- to high-risk patients receiving prophylactic rectal NSAIDs (FLUYT trial): study protocol for a randomized controlled trial

Author

Arts-assistenten Radiologie, MS CGO, Cancer, Smeets, Xavier J N M, da Costa, David W, Fockens, Paul, Mulder, Chris J J, Timmer, Robin, Kievit, Wietske, Zegers, Marieke, Bruno, Marco J, Besselink, Marc G H, Vleggaar, Frank P, van der Hulst, Rene W M, Poen, Alexander C, Heine, Gerbrand D N, Venneman, Niels G, Kolkman, Jeroen J, Baak, Lubbertus C, Römkens, Tessa E H, van Dijk, Sven M, Hallensleben, Nora D L, van de Vrie, Wim, Seerden, Tom C J, Tan, Adriaan C I T L, Voorburg, Annet M C J, Poley, Jan-Werner, Witteman, Ben J, Bhalla, Abha, Hadithi, Muhammed, Thijs, Willem J, Schwartz, Matthijs P, Vrolijk, Jan Maarten, Verdonk, Robert C, van Delft, Foke, Keulemans, Yolande, van Goor, Harry, Drenth, Joost P H, van Geenen, Erwin J M, Dutch Pancreatitis Study Group, Arts-assistenten Radiologie, MS CGO, Cancer, Smeets, Xavier J N M, da Costa, David W, Fockens, Paul, Mulder, Chris J J, Timmer, Robin, Kievit, Wietske, Zegers, Marieke, Bruno, Marco J, Besselink, Marc G H, Vleggaar, Frank P, van der Hulst, Rene W M, Poen, Alexander C, Heine, Gerbrand D N, Venneman, Niels G, Kolkman, Jeroen J, Baak, Lubbertus C, Römkens, Tessa E H, van Dijk, Sven M, Hallensleben, Nora D L, van de Vrie, Wim, Seerden, Tom C J, Tan, Adriaan C I T L, Voorburg, Annet M C J, Poley, Jan-Werner, Witteman, Ben J, Bhalla, Abha, Hadithi, Muhammed, Thijs, Willem J, Schwartz, Matthijs P, Vrolijk, Jan Maarten, Verdonk, Robert C, van Delft, Foke, Keulemans, Yolande, van Goor, Harry, Drenth, Joost P H, van Geenen, Erwin J M, and Dutch Pancreatitis Study Group

Published
2018

45. Laparoscopic left sectionectomy

Author

van der Poel, Marcel J., Tanis, Pieter J., Wicherts, Dennis A., Besselink, Marc G. H., Valentin, Cuesta, Angel, Miguel, Graduate School, Surgery, Amsterdam Gastroenterology Endocrinology Metabolism, Cancer Center Amsterdam, and APH - Methodology

Published
2017

48. Minimally invasive versus open distal pancreatectomy (LEOPARD) : study protocol for a randomized controlled trial

Author

de Rooij, Thijs, van Hilst, Jony, Vogel, Jantien A, van Santvoort, Hjalmar C, de Boer, Marieke T., Boerma, Djamila, van den Boezem, Peter B., Bonsing, Bert A., Bosscha, Koop, Coene, Peter-Paul, Daams, Freek, van Dam, Ronald M., Dijkgraaf, Marcel G. W., van Eijck, Casper H., Festen, Sebastiaan, Gerhards, Michael F., Groot Koerkamp, Bas, Hagendoorn, Jeroen, van der Harst, Erwin, de Hingh, Ignace H., Dejong, Cees H., Kazemier, Geert, Klaase, Joost M., de Kleine, Ruben H J, van Laarhoven, Cornelis J., Lips, Daan J., Luyer, Misha Dp, Molenaar, I Quintus, Nieuwenhuijs, Vincent B., Patijn, Gijs A., Roos, Daphne, Scheepers, Joris Jg, Van Der Schelling, George P., Steenvoorde, Pascal, Swijnenburg, Rutger-Jan, Wijsman, Jan H, Abu Hilal, Moh'd, Busch, Olivier R C, Besselink, Marc G H, Dutch Pancreatic Cancer Group, de Rooij, Thijs, van Hilst, Jony, Vogel, Jantien A, van Santvoort, Hjalmar C, de Boer, Marieke T., Boerma, Djamila, van den Boezem, Peter B., Bonsing, Bert A., Bosscha, Koop, Coene, Peter-Paul, Daams, Freek, van Dam, Ronald M., Dijkgraaf, Marcel G. W., van Eijck, Casper H., Festen, Sebastiaan, Gerhards, Michael F., Groot Koerkamp, Bas, Hagendoorn, Jeroen, van der Harst, Erwin, de Hingh, Ignace H., Dejong, Cees H., Kazemier, Geert, Klaase, Joost M., de Kleine, Ruben H J, van Laarhoven, Cornelis J., Lips, Daan J., Luyer, Misha Dp, Molenaar, I Quintus, Nieuwenhuijs, Vincent B., Patijn, Gijs A., Roos, Daphne, Scheepers, Joris Jg, Van Der Schelling, George P., Steenvoorde, Pascal, Swijnenburg, Rutger-Jan, Wijsman, Jan H, Abu Hilal, Moh'd, Busch, Olivier R C, Besselink, Marc G H, and Dutch Pancreatic Cancer Group

Published
2017

49. Minimally invasive versus open distal pancreatectomy (LEOPARD): study protocol for a randomized controlled trial

Author

MS CGO, Cancer, de Rooij, Thijs, van Hilst, Jony, Vogel, Jantien A, van Santvoort, Hjalmar C, de Boer, Marieke T., Boerma, Djamila, van den Boezem, Peter B., Bonsing, Bert A., Bosscha, Koop, Coene, Peter-Paul, Daams, Freek, van Dam, Ronald M., Dijkgraaf, Marcel G. W., van Eijck, Casper H., Festen, Sebastiaan, Gerhards, Michael F., Groot Koerkamp, Bas, Hagendoorn, Jeroen, van der Harst, Erwin, de Hingh, Ignace H., Dejong, Cees H., Kazemier, Geert, Klaase, Joost M., de Kleine, Ruben H J, van Laarhoven, Cornelis J., Lips, Daan J., Luyer, Misha Dp, Molenaar, I Quintus, Nieuwenhuijs, Vincent B., Patijn, Gijs A., Roos, Daphne, Scheepers, Joris Jg, Van Der Schelling, George P., Steenvoorde, Pascal, Swijnenburg, Rutger-Jan, Wijsman, Jan H, Abu Hilal, Moh'd, Busch, Olivier R C, Besselink, Marc G H, Dutch Pancreatic Cancer Group, MS CGO, Cancer, de Rooij, Thijs, van Hilst, Jony, Vogel, Jantien A, van Santvoort, Hjalmar C, de Boer, Marieke T., Boerma, Djamila, van den Boezem, Peter B., Bonsing, Bert A., Bosscha, Koop, Coene, Peter-Paul, Daams, Freek, van Dam, Ronald M., Dijkgraaf, Marcel G. W., van Eijck, Casper H., Festen, Sebastiaan, Gerhards, Michael F., Groot Koerkamp, Bas, Hagendoorn, Jeroen, van der Harst, Erwin, de Hingh, Ignace H., Dejong, Cees H., Kazemier, Geert, Klaase, Joost M., de Kleine, Ruben H J, van Laarhoven, Cornelis J., Lips, Daan J., Luyer, Misha Dp, Molenaar, I Quintus, Nieuwenhuijs, Vincent B., Patijn, Gijs A., Roos, Daphne, Scheepers, Joris Jg, Van Der Schelling, George P., Steenvoorde, Pascal, Swijnenburg, Rutger-Jan, Wijsman, Jan H, Abu Hilal, Moh'd, Busch, Olivier R C, Besselink, Marc G H, and Dutch Pancreatic Cancer Group

Published
2017

50. Hospital of diagnosis and likelihood of surgical treatment for pancreatic cancer

Author

Bakens, M. J A M, van Gestel, Yvette R B M, Bongers, M., Besselink, Marc G H, Dejong, C.H.C., Molenaar, I. Q., Busch, Olivier R C, Lemmens, Valery E. P. P., de Hingh, Ignace H J T, and the Dutch Pancreatic Cancer Group

Subjects
Surgery
Abstract

Background: Surgical resection for pancreatic cancer offers the only chance of cure. Assessment of the resectability of a pancreatic tumour is therefore of great importance. The aim of the study was to investigate whether centre of diagnosis influences the likelihood of surgery and whether this affects long-term survival. Methods: Patients diagnosed with non-metastasized pancreatic cancer (M0) between 2005 and 2013 in the Netherlands were selected from the Netherlands Cancer Registry. Hospitals were classified as a pancreatic centre (at least 20 resections/year) or a non-pancreatic centre (fewer than 20 resections/year). The relationship between centre of diagnosis and likelihood of surgery was analysed by multivariable logistic regression. Influence of centre on overall survival was assessed by means of multivariable Cox regression analysis. Results: Some 8141 patients were diagnosed with non-metastasized pancreatic cancer, of whom 3123 (38·4 per cent) underwent surgery. Of the 2712 patients diagnosed in one of 19 pancreatic centres, 52·4 per cent had exploratory laparotomy compared with 31·4 per cent of 5429 patients diagnosed in one of 74 non-pancreatic centres (P < 0·001). A pancreatectomy was performed in 42·8 and 24·6 per cent of the patients respectively (P < 0·001). Multivariable analysis revealed that patients diagnosed in a pancreatic centre had a higher chance of undergoing surgery (odds ratio 2·21, 95 per cent c.i. 1·98 to 2·47). Centre of diagnosis was not associated with improved long-term survival (hazard ratio 0·95, 95 per cent c.i. 0·91 to 1·00). Conclusion: Patients with non-metastasized pancreatic cancer had a greater likelihood of having surgical treatment when the diagnosis was established in a pancreatic centre.

Published
2015

Catalog

Books, media, physical & digital resources
See catalog results